Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Czechlateon Jul 14, 2014 1:53pm
144 Views
Post# 22743458

RE:RE:RE:grf okay i checked 40%

RE:RE:RE:grf okay i checked 40%
You missed couple key things when you re read that news...Pay close attention here. Dont forget MMAR licenses will be canceled once MMPR system is implemented... The Proposed Transaction Under the proposed terms and conditions, and following the signature of the definitive agreement (the "Definitive Agreement"), Matica and ChroniCare will form a JV to establish a marijuana growing operation in Ontario with the intent of becoming licensed under the Marijuana for Medical Purposes Regulations ("MMPR"). There can be no assurance that the JV will apply for a license or that such a license will ultimately be granted. Matica will have a 60% interest and ChroniCare will have a 40% interest in the JV. Matica will provide financing for the new JV up to an aggregate of $1,500,000. ChroniCare will act as operator of the JV and provide its expertise related to marijuana growing. Matica will further issue to ChroniCare 500,000 shares of Matica shares upon execution of the Definitive Agreement. The Proposed Transaction is an arm's length transaction. Completion of the Proposed Transaction is subject to a number of conditions, including but not limited to: (a) entering into the Definitive Agreement; (b) completion of due diligence; (c) CSE acceptance; and (d) if necessary, Matica shareholder approval. The Proposed Transaction cannot close until the conditions are satisfied. There can be no assurance that the Proposed Transaction will be completed as proposed or at all. Trading in the securities of Matica should be considered highly speculative. Should the JV opt to become a producer and choose to make an application, we will need to complete Health Canada's Application To Become A Licenced Producer Under The Marijuana For Medical Purposes Regulations (MMPR). Any Canadian based project would need to meet stringent requirements as outlined by Health Canada. Any entity applying for a license from Health Canada would need to be an indoor facility equipped with physical barriers which prevent unauthorized entry in to the facility and further physical barriers to all growing areas are required.
Bullboard Posts